Annual Global Discovery to Development Innovation Forum Speakers
Dr. Immanuel Lerner is Pepticom’s CEO since 2014, co-founder and board member. Pepticom is using Artificial intelligence for peptide discovery for collaborations and internal projects. Dr. Lerner holds a Ph.D. in biochemistry followed by postdoctoral from the Hebrew University of Jerusalem, during his studies he published his research in leading journals (with the honor of publishing his postdoc research with the 2018 Nobel laureate in Physiology/Medicine Prof. Michael Rosbash). As CEO was responsible for the establishment of pepticom’s biological R&D and led Pepticom from a “garage” start-up to market penetration a revenue generating company (>$2M). Was responsible for defining and executing the technological and business vision of the company, while building and leading Pepticom’s team.